Candidiasis
is a type of infection caused due to candida—an yeast and also
classified as fungus, which is present in the human body. It is
usually present in places like mouth, belly, and on the skin. The
overgrowth of these leads to an infection. This dormant yeast can
lead to candida infection at any stage in a person’s life and is
closely linked to the immunity level of the person. There are various
types of infections caused due to candidiasis, such as thrush/
oropharyngeal candidiasis, genital yeast infection/ invasive
infection, and cutaneous candidiasis. Thrush/ oropharyngeal
candidiasis affects the mouth or throat; genital yeast infection
affects the vagina; and cutaneous candidiasis is the infection of the
skin. When the infection enters into the blood stream, the condition
is called Candidemia. Candidiasis can be diagnosed by physical
observation. These conditions are usually treated using
over-the-counter antifungal medicines and also specific
prescription-based antifungal medicines.
Download
PDF Brochure of This Business Report @
https://www.coherentmarketinsights.com/insight/request-pdf/229
Increasing
consumer awareness about candidiasis and growing number of treatment
options are major factors fueling growth of the candidiasis market.
Conversely, dearth of R&D activities, low product availability,
and easy access to alternative treatment methods such as use of
herbal medicines inhibits growth of the candidiasis market.
Rising
awareness regarding the infection and increasing patient pool to
favor the growth of Candidiasis market
Rising
awareness about the infections is expected to cause the growth of
candidiasis market. Increasing focus of various governments in the
APAC region, such as in highly populous China and India, on improving
the healthcare infrastructure, along with increasing consumer
awareness about the condition is expected to position the region on a
high growth trajectory in the global candidiasis industry over the
forecast period (2016–2024). Candidiasis are treated using various
treatment option such as oral medication, injection, and ointments.
Candidiasis can infect males, females and also newborn babies. The
condition is notoriously hard to treat in people suffering from
diabetes, cancer, AIDS, and also pregnant women. As per stats
released by Centers for Disease Control and Prevention (CDC), around
75% of would suffer from at least one vaginal candida infection in
their whole life, while 40-45% would suffer twice or more.
Developed
Regions Growth Engine of Candidiasis Market
In
developed countries, increasing number of organ transplantation, use
of catheters, artificial valves, and joints causing to growth of
candida infection. The North America and Europe regions account for
the largest market share, due to high awareness about the infection,
wide availability of treatment and easy access to OTC antifungal
drugs creates a highly conducive environment for growth of the
market. Azole Drugs holds large market share, with products such as
Vfend, Noxafil, and Diflucan being highly preferred among the masses.
Major
Key Players
The
major market players in Candidiasis market are Bayer, Teva
Pharmaceuticals, Stellar Pharma, Pfizer, Wockhardt, Glenmark
Pharmaceuticals, Ranbaxy, Taro Pharmaceuticals, and Bristol
Laboratories, among others.
Candidiasis
Market Taxonomy:
This
market is segmented by as follows-
By
Route of Administration:
-
Oral
-
Parenteral
-
Topical
By
Type of Infection:
-
Thrush/ oropharyngeal candidiasis
-
Genital Yeast Infection/ Invasive infection
-
Cutaneous Candidiasis
Browse
In-Depth Analysis Research Report @
https://www.coherentmarketinsights.com/ongoing-insight/candidiasis-market-229
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm
offering action-ready syndicated research reports, custom market
analysis, consulting services, and competitive analysis through
various recommendations related to emerging market trends,
technologies, and potential absolute dollar opportunity.
Contact
Us:
Mr.
Shah
Coherent
Market Insights
1001
4th Ave,
#3200
Seattle,
WA 98154
Tel:
+1-206-701-6702
No comments:
Post a Comment